SLFN11 is necessary for single agent sensitivity to talazoparib, a potent PARP inhibitor, but not for radiosensitization in small cell lung cancer (SCLC) cell lines and patient-derived xenografts (PDX) Meeting Abstract
| Authors: | Lok, B. H.; Feng, Y.; Gardner, E. E.; Yu, G. K.; Ru, Y. K.; Riaz, N.; deStanchina, E.; Powell, S. N.; Shen, Y. J.; Poirier, J. T.; Rudin, C. M. |
| Abstract Title: | SLFN11 is necessary for single agent sensitivity to talazoparib, a potent PARP inhibitor, but not for radiosensitization in small cell lung cancer (SCLC) cell lines and patient-derived xenografts (PDX) |
| Meeting Title: | 58th Annual Meeting of the American Society for Radiation Oncology (ASTRO) |
| Journal Title: | International Journal of Radiation Oncology, Biology, Physics |
| Volume: | 96 |
| Issue: | 2 Suppl. |
| Meeting Dates: | 2016 Sep 25-28 |
| Meeting Location: | Boston, MA |
| ISSN: | 0360-3016 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2016-10-01 |
| Start Page: | S75 |
| Language: | English |
| ACCESSION: | WOS:000387655804506 |
| PROVIDER: | wos |
| DOI: | 10.1016/j.ijrobp.2016.06.191 |
| Notes: | Meeting Abstract: 169 -- 58th Annual Meeting of the American-Society-for-Radiation-Oncology -- SEP 25-28, 2016 -- Boston, MA -- Source: Wos |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work